Hologic (HOLX) Competitors $64.59 -1.79 (-2.69%) As of 03:23 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HOLX vs. HQY, HSIC, MASI, MMSI, ALC, AMN, AVNS, HAE, PEN, and ZBHShould you be buying Hologic stock or one of its competitors? The main competitors of Hologic include HealthEquity (HQY), Henry Schein (HSIC), Masimo (MASI), Merit Medical Systems (MMSI), Alcon (ALC), AMN Healthcare Services (AMN), AVANOS MEDICAL (AVNS), Haemonetics (HAE), Penumbra (PEN), and Zimmer Biomet (ZBH). These companies are all part of the "medical" sector. Hologic vs. Its Competitors HealthEquity Henry Schein Masimo Merit Medical Systems Alcon AMN Healthcare Services AVANOS MEDICAL Haemonetics Penumbra Zimmer Biomet HealthEquity (NASDAQ:HQY) and Hologic (NASDAQ:HOLX) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, media sentiment, analyst recommendations and earnings. Does the media prefer HQY or HOLX? In the previous week, Hologic had 3 more articles in the media than HealthEquity. MarketBeat recorded 24 mentions for Hologic and 21 mentions for HealthEquity. Hologic's average media sentiment score of 1.36 beat HealthEquity's score of 1.20 indicating that Hologic is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 14 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hologic 18 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is HQY or HOLX more profitable? Hologic has a net margin of 13.79% compared to HealthEquity's net margin of 11.49%. Hologic's return on equity of 19.69% beat HealthEquity's return on equity.Company Net Margins Return on Equity Return on Assets HealthEquity11.49% 12.04% 7.44% Hologic 13.79%19.69%10.82% Do insiders and institutionals believe in HQY or HOLX? 99.6% of HealthEquity shares are held by institutional investors. Comparatively, 94.7% of Hologic shares are held by institutional investors. 1.5% of HealthEquity shares are held by company insiders. Comparatively, 1.9% of Hologic shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has preferable valuation and earnings, HQY or HOLX? Hologic has higher revenue and earnings than HealthEquity. Hologic is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHealthEquity$1.20B6.66$96.70M$1.6556.22Hologic$4.04B3.56$789.50M$2.4126.80 Which has more risk & volatility, HQY or HOLX? HealthEquity has a beta of 0.5, indicating that its stock price is 50% less volatile than the S&P 500. Comparatively, Hologic has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Do analysts prefer HQY or HOLX? HealthEquity presently has a consensus target price of $119.77, indicating a potential upside of 29.10%. Hologic has a consensus target price of $78.00, indicating a potential upside of 20.75%. Given HealthEquity's stronger consensus rating and higher possible upside, research analysts clearly believe HealthEquity is more favorable than Hologic.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HealthEquity 0 Sell rating(s) 1 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 3.00Hologic 0 Sell rating(s) 8 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.59 SummaryHologic beats HealthEquity on 10 of the 16 factors compared between the two stocks. Get Hologic News Delivered to You Automatically Sign up to receive the latest news and ratings for HOLX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HOLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HOLX vs. The Competition Export to ExcelMetricHologicMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.34B$6.82B$5.82B$10.17BDividend YieldN/A1.23%5.69%4.60%P/E Ratio26.7526.0274.6725.98Price / Sales3.5662.87454.5485.61Price / Cash11.9121.6337.0859.91Price / Book2.925.0112.186.31Net Income$789.50M$176.38M$3.29B$270.86M7 Day Performance-3.24%1.17%1.08%3.46%1 Month Performance-4.94%3.39%7.32%6.57%1 Year Performance-19.68%12.54%63.11%28.39% Hologic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HOLXHologic4.9218 of 5 stars$64.59-2.7%$78.00+20.8%-17.0%$14.34B$4.04B26.757,063Positive NewsHQYHealthEquity4.446 of 5 stars$89.33+1.2%$117.82+31.9%+22.9%$7.72B$1.24B65.203,120Positive NewsHSICHenry Schein3.8516 of 5 stars$69.58+0.8%$76.67+10.2%+3.7%$8.44B$12.67B22.4525,000MASIMasimo4.7964 of 5 stars$139.71-0.9%$193.60+38.6%+28.0%$7.59B$2.09B-16.405,600News CoverageMMSIMerit Medical Systems4.7731 of 5 stars$90.54+0.5%$107.00+18.2%-7.1%$5.36B$1.36B45.967,400Positive NewsALCAlcon3.4628 of 5 stars$79.82+0.5%$96.06+20.4%-18.9%$39.37B$9.91B37.1225,599AMNAMN Healthcare Services4.6573 of 5 stars$20.77+3.6%$28.25+36.0%-56.0%$795.98M$2.98B-2.672,968News CoverageAnalyst ForecastShort Interest ↓Analyst RevisionAVNSAVANOS MEDICAL2.1298 of 5 stars$11.93+0.5%N/A-47.3%$553.74M$687.80M-1.192,227Positive NewsHAEHaemonetics4.9253 of 5 stars$54.63+0.5%$85.18+55.9%-26.1%$2.63B$1.36B16.712,820News CoveragePositive NewsAnalyst RevisionPENPenumbra4.6088 of 5 stars$272.96+0.5%$300.47+10.1%+36.8%$10.65B$1.19B72.604,500ZBHZimmer Biomet4.7887 of 5 stars$106.11+1.0%$111.44+5.0%-0.9%$21.02B$7.68B25.8217,000Positive NewsInsider Trade Related Companies and Tools Related Companies HealthEquity Alternatives Henry Schein Alternatives Masimo Alternatives Merit Medical Systems Alternatives Alcon Alternatives AMN Healthcare Services Alternatives AVANOS MEDICAL Alternatives Haemonetics Alternatives Penumbra Alternatives Zimmer Biomet Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HOLX) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCollege grad makes $64,000 a monthIt's easy to feel like you've missed out on the biggest stock market boom of the century. But if you want t...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredElon’s new AI play could hand regular Americans a Tesla‑like paydayElon Musk just launched his boldest AI project yet... And if history is any guide — it could make early inv...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hologic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hologic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
